Ancient healing meets modern science: korean medicine tested for facial paralysis
NCT ID NCT04905745
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether Korean integrative medicine, including Chua therapy, can help people with Bell's palsy recover facial movement and emotional well-being. Researchers will follow 100 adults aged 19-69 who have had facial palsy for less than three weeks. The main goal is to see if their facial function and quality of life improve over three months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Korean integrative medicine (including Chuna therapy)
- What this could lead to
- If successful, this could point toward a safe, non-invasive treatment option for Bell's palsy that improves facial movement and emotional health.
- What could go wrong
- This is a small, early observational study with no control group, so results may not prove the treatment works better than natural recovery. Individual responses vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2021
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
adulthood male and female patients with peripheral facial nerve palsy
- Ages
-
19 to 69 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. age of 19 to 69 2. diagnosed with unilateral peripheral facial nerve palsy 3. onset of facial palsy within 3 weeks or less. 4. an individual who can provide written consent form to participate in the study. Exclusion Criteria: 1. diagnosed with central nervous system disease causing facial palsy 2. secondary facial palsy after multiple sclerosis, tumor, cerebrovascular disease and temporal bone fracture. 3. Ramsay-Hunt syndrome 4. bilateral or recurrent facial nerve palsy. 5. an individual who received any treatment that can have a significant effect on changes in facial paralysis within recent 2 month. (ie. facial nerve decompression surgery) 6. already or planned to be pregnant or breast-feeding within the study period. 7. uncontrolled diabetes mellitus within the last 3 months. 8. within a month after participating any other facial palsy-related clinical trials, or planning to participate other clinical trials within 6 month. 9. impossible to read and understand the documents, regarding informed consent form and the questionnaires. 10. difficult to participate according to the judgement of researchers.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Facial paralysis, peripheral are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Jaseng Hospital of Korean Medicine
RECRUITINGSeoul, Gangnam-Gu, 135-896, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.